Brookline Capital Markets Stock Recommendations and Price Targets

This is a list of recent ratings by Brookline Capital Markets.

DateCompany NameActionCurrent
Price
Price
Target
Rating
6/11/2026
ADIL
Adial Pharmaceuticals
Downgrade$3.00Strong-Buy ➝ Hold
6/8/2026
KYMR
Kymera Therapeutics
Reiterated Rating$90.00Buy ➝ Buy
5/20/2026
PMN
Promis Neurosciences
Upgrade$11.00Strong-Buy
5/7/2026
ERNA
Ernexa Therapeutics
Initiated Coverage$6.00 $30.00Buy